RFK Jr. Funds Ibogaine PTSD Research

HHS Secretary Robert F. Kennedy Jr. announced up to $4.9 million in federal funding through ARPA-H–in partnership with Mark Cuban’s Cost Plus Drug Company–to prepare the psychedelic drug ibogaine for U.S. PTSD clinical trials.

Learn more about your ad choices. Visit podcastchoices.com/adchoices